424 General Military Hospital
2 clinical trials · 2 recruiting · OTHER
Trials by 424 General Military Hospital
RECRUITINGNCT05575167
Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
A 24-month prospective, open-label, randomized, multicenter, multinational, non-inferiority pragmatic clinical trial evaluating zoledronate single or double infusion versus oral...
Sponsor: 424 General Military HospitalEnrolling: 1259 locations
Osteoporosis, Postmenopausal
RECRUITINGNCT06164795
Sequential Therapies After Osteoanabolic Treatment
12-month prospective, open-label, multicenter, international, observational study evaluating sequential treatments after osteoanabolics
Sponsor: 424 General Military HospitalEnrolling: 1508 locations
Osteoporosis, Postmenopausal